Gyre Therapeutics (GYRE) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.11% |
| Dec 31, 2025 | -41.75% |
| Sep 30, 2025 | 43.29% |
| Jun 30, 2025 | 33.86% |
| Mar 31, 2025 | -40.96% |
| Dec 31, 2024 | -45.65% |
| Sep 30, 2024 | -16.69% |
| Jun 30, 2024 | -33.62% |
| Mar 31, 2024 | -23.16% |
| Dec 31, 2023 | -20.27% |
| Sep 30, 2023 | -8.22% |
| Jun 30, 2023 | 35.59% |
| Mar 31, 2023 | -63.05% |
| Dec 31, 2022 | -114.66% |
| Jun 30, 2022 | 780.33% |
| Mar 31, 2022 | -18.11% |
| Dec 31, 2021 | -13.27% |
| Sep 30, 2021 | 24.18% |
| Jun 30, 2021 | 31.00% |
| Mar 31, 2021 | 56.25% |
| Dec 31, 2020 | 20.21% |
| Sep 30, 2020 | -22.90% |
| Jun 30, 2020 | -144.00% |
| Mar 31, 2020 | 162.26% |
| Sep 30, 2019 | 28.98% |
| Jun 30, 2019 | -13.33% |
| Mar 31, 2019 | 34.96% |
| Dec 31, 2018 | 19.50% |
| Sep 30, 2018 | -19.39% |
| Jun 30, 2018 | -84.25% |
| Mar 31, 2018 | 17.93% |
| Dec 31, 2017 | -15.95% |
| Sep 30, 2017 | -24.44% |
| Jun 30, 2017 | -14.89% |
| Mar 31, 2017 | 0.02% |
| Dec 31, 2016 | 36.08% |
| Sep 30, 2016 | 16.28% |
| Jun 30, 2016 | 28.55% |
| Mar 31, 2016 | 7.40% |
| Dec 31, 2015 | 30.33% |
| Sep 30, 2015 | 27.12% |